Loading organizations...
Loading organizations...
Biotechnology company developing targeted cancer therapeutics.
Iterion Therapeutics has raised $17.0M across 1 funding round.
Iterion Therapeutics has raised $17.0M in total across 1 funding round.
Iterion Therapeutics has raised $17.0M in total across 1 funding round.
Iterion Therapeutics's investors include Benjamin Rovinski, Ph.D., Green Park & Golf Ventures, Sante Ventures, Venture Investors.
Iterion Therapeutics has raised $17.0M across 1 funding round. Most recently, it raised $17.0M Series B in February 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Feb 16, 2021 | $17.0M Series B | Benjamin Rovinski, Ph.D. | Green Park & Golf Ventures, Sante Ventures, Venture Investors |